Members

If you want to participate in the Norwegian Nanomedicine Network, please contact the

Name:	Company:	Field of interest:	Phone:	E-mail:
Heidi Johnsen Ruth Schmid Per Stenstad	SINTEF Materials and Chemistry	• Targeted drug delivery • Modifications and functionalisation of nanoparticles • Combined diagnostics and therapy • Sensor applications	+ 47 98243914 + 47 93036337 + 47 98243916
Toril A Nagelhus Hernes	SINTEF Medical technology	• Molecular imaging, MR, Ultrasound, CT • Image guided therapy • Drug delivery • Cancer and vascular lesions	+ 47 93028341
Anders Høgset	PCI Biotech AS	• Targeted drug and macromolecule delivery • Light-induced, site-sepcific drug delivery • Gene and oligonucleotide therapy	+47 23254003
Silvija Jarnjak-Jankovic	The Norwegian Radium Hospital, Section for immunotherapy	• Nanomedicin and cancer treatment	+47 93011032
Kristian Berg	The Norwegian Radium Hospital, Dept. of Radiation Biology	• Targeted macromolecule delivery • Photochemically induced drug delivery • Adenovirus and oligonucleotide therapy	+47 22 93 42 60
Petras Juzenas	Department of Radiation Biology Institute for Cancer Research Rikshospitalet-Radiumhospitalet Medical Centre	• Nanoparticles for diagnosis and therapy of cancer • Uptake and toxicity of quantum dots • Radical mechanisms of drug action • Release of encapsulated drugs from liposomes	+47 22781205
Tore-Geir Iversen	Department of Biochemistry, Institute for Cancer Research, Centre for Cancer Biomedicine, University of Oslo. Rikshospitalet-Radiumhospitalet Medical Center	• Targeted drug delivery and diagnostic imaging systems • Endocytosis and intracellular transport and transcytosis of nanoparticles • Nanotoxicity	+47 22934293
Peyman Mirtaheri	Høgskolen i Oslo, Elektro	• Miniaturized Biosensors for metabolic activities in cell cultures and tissue • New biosensing schemes based on nano materials. • Biomaterials • Bioelectronic devices	+47 22453271
Jacob Bergsland	Rikshospitalet, The Interventional Centre	• use of smart metals and polymers to perform intracardiac repairs using minimally invasive approaches.	+ 47 93031292
Magali LE BOMIN	Polypure AS	• PEG spacers/linkers • Surface modification, SAMs Formation • New conjugation chemistry • Pegylation technology	+ 47 22958329
Erik Joner	Bioforsk Soil and Environment	• Fate and ecotoxicity of nanomaterials in the environment, including nano-based pharmaceuticals • Methods for detection of nanoparticles in organisms and environmental matrices • Risk assessment of nanomaterials released in the environment • Microbial modification of nanomaterials	+47 92833168
Bjarne Bogen	University of Oslo	• Immunologi, cellulære biologi, flowcytometri, in vivo imaging	+ 47
Erik Fosse	The Interventional centre, Rikshospitalet-Radiumhospitalet Medical Centre, University of Oslo	• Biosensors • Biocompatible surfaces in biosensors • Nanorobotics • Drug packaging for targetd drug delivery	+47 23070116
Øyvind Halaas	Institutt for kreftforskning og molekylærmedisin, DMF, NTNU	• Course coordinator Nanomedicine, NTNU • Targeted delivery of vaccines • Intracellular trafficking	+47 73598673
Marit Sletmoen	Biophysics and Medical Technology, Department of Physics, The Norwegian University of Science and Technology, NTNU, NO 7491 Trondheim	• molecular pair interactions studied at the single molecule level (dynamic force spectroscopy) • single molecule imaging • biopolymer gels /soft biomaterials	+47 73593463
Bjørn Torger Stokke	Biophysics and Medical Technology, Department of Physics, The Norwegian University of Science and Technology, NTNU, NO 7491 Trondheim	• Chitosan-based nanoparticles for non-viral gene delivery is a novel approach to selective transfection in vivo. Nanofabrication and manipulation of chitosan complexes enables tailor-making of non-viral gene delivery vehicles for therapeutic purposes. • Bioresponsive materials as signal transducers for optical detection of specific biological molecules allow biosensing in an environment requiring non-magnetic materials as in e.g. MRI. The materials being developed aim at integration of specific molecules related to the particular diagnostic situation at hand	+47 73593434
Tore Syversen	Norwegian University of Science and technology, Faculty of Medicine, department of Neuroscience	• In vitro toxicology testing • Health risk assessment	+47 73598848
Olav Haraldseth	Norwegian University of Science and Technology (NTNU)	• Smart contrast agents of nanoparticle size for MR and Ultrasound imaging • MR and ultrasound technology for improved sensitivity for MR and ultrasound contrast agents • MR and Ultrasound used for guidance and monitoring of regenerative medicine	+47 98468940
Catharina de Lange Davies	Dept. of physics, Norwegian University of Science and Technology	• to study the mechanisms of transport of macromolecules in tumour tissue; • characterise the distribution of therapeutic macromolecules in tumour tissue in situ, and correlate the distribution with physiological parameters important for the transport; • explore how physical (ultrasound and ionising radiation) and chemical (enzymes) treatments can increase the uptake and improve the distribution of macromolecules in tumours.	+47 73593688
Sabina P. Strand	NTNU, Institute for Biotechnology/NOBIPOL	• gene and siRNA delivery • biopolymer (chitosan) based delivery systems	+ 47 73591689
Christian Brekken	Norwegian University of Science and Technology	Nanostructured contrast agents for medical imaging: • Slow contrast agent delivery • Nanoparticles • Targeted contrast agents • Theranostics	+47 73551354
Martin Brandl	University of Tromsoe, Drug Transport and Delivery Group	• Lipid-based nanoparticles (liposomes) as drug delivery systems • Particle size analysis of nanoparticles • Sterile and aseptic manufacturing of drugs • Cytostatic nanomedicines	+47 77646159
Staale Petter Lyngstadaas	Department for Biomaterials, Faculty of Dentistry, University of Oslo	• Nanostructured biomaterial surfaces for bone engineering • Self assembly molecules in extracellular matrices and mineral deposition templating • Controlled ion implementation and activation of metal surfaces • Real-time nano imaging of surfaces of living cells	+47 22852350 +47 22852357
Solveig Kristensen	School of Pharmacy, Dept. of Pharmacy, University of Oslo	Drug formulation by use of drug-carrier systems (cyclodextrins, micelles, nanoparticles, liposomes) to obtain solubilzation of lipophilic compounds and increased bioavailability, to enhance drug stability and to obtain drug targeting.	+ 47 22854218
Astrid Hilde Myrset Per A. Foss	GE Healthcare AS	• Selection and development of molecular agents for functional or targeted diagnostic imaging • Nanoparticles for use in biomedicine • Molecular imaging probes	+47 23185576 +47 23185422
-	siRNAsense AS	RNA interference, siRNA: • Focus fields are cancer, neuroscience and heart disease • also interested in discussing possibilities in other fields of RNA interference	+ 47 22958192

Published May 10, 2007